is semaglutide a weight loss drug vs Tirzepatide: Which Better for Loss? Semaglutide for Weight Loss Management

The SELECT cardiovascular outcomes trial showed that semaglutide 2.4 mg significantly reduced major adverse cardiovascular events (heart attack, stroke, and cardiovascular death) in patients with established cardiovascular disease and overweight or obesity, even without type 2 diabetes

ACETAMINOPHEN ASSAYS - INTERPRETATION AND METHODOLOGY The acute ingestion of acetaminophen in quantities of 150 mg/kg or greater may result in hepatic toxicity

Weight gain can occur with insulin-containing products, including Soliqua, and has been attributed to the tissue-building (anabolic) effects of insulin, as noted by the manufacturer

This dual dysfunction of microglia and astrocytes leads to extensive oxidative stress, immune activation, and eventual neuronal degradation